Aureon Laboratories focused on developing the advancement of predictive and personalized cancer treatment options.
Aureon Laboratories is a life sciences company dedicated to enabling the advancement of predictive and personalized cancer treatment. Aureon provides objective, actionable information allowing patients and physicians to make more-informed treatment decisions through its prostate diagnostic tools.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 14, 2010 | Series D | $7M | 1 | — | — | Detail |
Mar 5, 2010 | Series C | — | 1 | — | — | Detail |